Industry
Sovereign AI for pharma & life sciences
AI over IP-critical research that never leaves your perimeter, owned, air-gapped, and trained on your science.
In short
Sovereign AI for pharma and life sciences is a model the organisation owns and runs inside its own perimeter, trained on its proprietary research and trial data, so IP-critical science never reaches a third party, the same approach Locai uses with research-intensive customers like First Light Fusion.
The IP problem in life sciences
In pharma and life sciences, the most valuable asset is unpublished research, compounds, trial data, and methods. Sending that to a general AI API means exposing your core IP to a third party, an unacceptable risk in a field where research advantage is everything.
Why public APIs fail here
- IP leakage: Proprietary research sent to an external model leaves your control.
- No air-gap: The most sensitive R&D environments can't call external APIs.
- Generic knowledge: A general model doesn't know your science or pipeline.
What owned AI enables in pharma
- Air-gapped R&D: Reason over confidential science on fully isolated infrastructure.
- Trained on your science: A model post-trained on your papers, datasets, and lab knowledge.
- Owned IP: The model, weights, and outputs belong to you, protecting research advantage.
What this looks like with Locai
What this looks like in a regulated sector is less about the technology and more about the procurement, deployment, and accountability story behind it.
Locai Labs believes organisations should own their intelligence. Renting access to a general-purpose model that lives on someone else's servers is fine for low-stakes work; for the AI that touches your data, your customers and your decisions, the model itself should be yours. That is the bet behind everything we build.
It is also a bet that an expert model beats a generalist on the work that actually matters to your business. A smaller model trained on your data, your language, your workflows and your edge cases routinely outperforms much larger generalists on the tasks you care about, and it does so on infrastructure you control. The goal is not the biggest model; the goal is the right model for your business.
And it is deployed sovereignly: an owned model that runs inside your perimeter, on-prem via Locai One, in your private cloud tenant, in a UK sovereign cloud, or fully air-gapped, depending on your residency and security requirements. Your prompts, your documents and your outputs stay inside your environment, under UK jurisdiction, with a data path designed to fit GDPR and the procurement standards regulated organisations are held to.
Frequently asked questions
Is AI safe for confidential research?
When the model is owned and runs inside your perimeter (or air-gapped), proprietary research never leaves your control, unlike a hosted API.
Can it run air-gapped for R&D?
Yes. Air-gapped deployment is ideal for IP-critical science, and is how Locai supports research-intensive customers.
Can it be trained on our science?
Yes, the model is post-trained on your papers, datasets, and lab knowledge so it reasons in your domain.
Who has done this already?
Locai deployed an air-gapped sovereign model for First Light Fusion, a leading fusion-energy company, to reason over confidential research inside their perimeter.
Book a sovereign AI briefing
A 30-minute session on owning your model: deployment options, the data path, and a clear cost range for your use case.